In order to achieve successful implementation of the National HIV/AIDS Strategy (NHAS), EHE and viral hepatitis programs, resources are needed to strategically coordinate HIV and viral hepatitis activities across the federal government. We urge you to fund the HHS Office of Infectious Disease and HIV/AIDS Policy at $7.6 million.
The HIV+Hepatitis Policy Institute respectfully submits this testimony in support of increased funding for domestic HIV and hepatitis programs at the Department of Health and Human Services for FY 2027. Specifically, this testimony is in support of funding for the following initiatives, programs and divisions: Ending the HIV Epidemic Initiative – $395 million for the CDC Division of HIV/AIDS Prevention, $358.6 million for the HRSA Ryan White HIV/AIDS Program, $207.3 million for the HRSA Community Health Centers, and $52 million for the Indian Health Service; Ryan White HIV/AIDS Program – $3.13 billion; CDC Division of HIV Prevention – $822.7 million; CDC Division of Viral Hepatitis – $150 million; and the HHS Office of Infectious Disease and HIV/AIDS Policy – $7.6 million. We also support maintaining funding for CDC’s Eliminating Opioid-Related Infectious Diseases Program and Division of Adolescent and School Health; the Minority HIV/AIDS Initiative; AIDS Research at the NIH; the Title X Family Planning Program; the Teen Pregnancy Prevention Program; and the SAMHSA Hepatitis C Elimination Initiative Pilot.
The HIV+Hepatitis Policy Institute strongly urges the Advisory Committee on Immunization Practices (ACIP) to maintain the recommendation of a universal hepatitis B birth dose in the United States. Maintaining this requirement will not only help prevent people from becoming ill but result in ending hepatitis B in our country, which is still a highly infectious disease.
We the undersigned 23 organizations urge you to protect and, if possible, increase funding for domestic viral hepatitis programs at the Centers for Disease Control and Prevention (CDC). At a time when we have tools including vaccines and curative treatments that can help eliminate viral hepatitis in the United States, we express our grave concern with the President’s FY 2026 budget request that eliminates $43 million in dedicated funding for hepatitis prevention. Instead, it proposes a $300 million block grant to states that would also include STD and tuberculosis prevention.
We the undersigned 22 organizations urge you to protect and, if possible, increase funding for domestic viral hepatitis programs at the Centers for Disease Control and Prevention (CDC). At a time when we have tools including vaccines and curative treatments that can help eliminate viral hepatitis in the United States, we express our grave concern with the President’s FY 2026 budget request that eliminates $43 million in dedicated funding for hepatitis prevention. Instead, it proposes a $300 million block grant to states that would also include STD and tuberculosis prevention.